<PAGE>
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
- - --------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Chase Venture Capital Associates, LLC ("CVCA, LLC")(FN 1)
- - --------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Chase Capital Partners
380 Madison Avenue, 12th Floor
- - --------------------------------------------------------------------------------
(Street)
New York, New York 10017
- - --------------------------------------------------------------------------------
(City) (State) (Zip)
- - --------------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year)
1/1/2000
- - --------------------------------------------------------------------------------
3. IRS Identification Number of Reporting Person, if an entity (Voluntary)
- - --------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
Diatide, Inc. ("DITI")
- - --------------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer
(Check all applicable)
|_| Director |X| 10% Owner
|_| Officer (give title below) |_| Other (specify below)
________________________________________
- - --------------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
09/23/97
- - --------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check applicable line)
|_| Form filed by One Reporting Person
|X| Form filed by More than One Reporting Person
================================================================================
- - --------------------------------------------------------------------------------
Table I -- Non-Derivative Securities Beneficially Owned
- - --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr. 4)
- - ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Common Stock 651,000 D
- - ------------------------------------------------------------------------------------------------------------------------------------
- - ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
* If the Form is filed by more than one Reporting Person see instruction
5(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
Page 1 of 7
<PAGE>
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
<CAPTION>
- - ------------------------------------------------------------------------------------------------------------------------------------
5. Owner-
3. Title and Amount of Securities ship
Underlying Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date --------------------------------- 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 7. Nature of
---------------------- or Exercise (D) or Indirect
Date Expira- Number Price of Indirect Beneficial
1. Title of Derivative Exer- tion of Derivative (I) Ownership
Security (Instr. 4) cisable Date Title Shares Security (Instr. 5) (Instr. 5)
- - ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Warrants Immed. 9/23/07 Common Stock 130,769 $11.70 D
(FN 2)
- - ------------------------------------------------------------------------------------------------------------------------------------
Series A Convertible Common Stock 871,795 0.00 (FN 3) D
Preferred Stock (FN 2)
- - ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
(1) Pursuant to an internal reorganization effective as of January 1, 2000, (i)
Chase Venture Capital Associates, LLC ("CVCA, LLC") became the successor to
Chase Venture Capital Associates, LP ("CVCA, LP"), (ii) CCP-SBIC Manager, LLC, a
newly organized wholly-owned subsidiary of Chase Capital Partners ("CCP"),
became the managing member of CVCA, LLC, and (iii) CCP-CMC Consolidating, LLC
("Consolidating"), a newly-organized affiliate of CCP, became the non-managing
member of CVCA, LLC. CCP is the managing member of Consolidating, and pursuant
to a master advisory agreement with CCP-SBIC Manager, LLC and Consolidating, the
manager, by delegation, of CVCA, LLC. Prior to the internal reorganization, CCP
was the general partner, and the sole shareholder of Consolidating was the
limited partner, of CVCA, LP. The internal reorganization changed CVCA, LP's
name and form of organization but did not alter the proportionate interests of
its ultimate security holders.
(2) These securities are owned solely by CVCA, LLC.
(3) These securities are initially convertible into Common Stock at a ratio of
1:1, subject to adjustment, without the payment of additional consideration.
Chase Venture Capital Associates, LLC 2/ /2000
- - --------------------------------------------- -----------------------
** Signature of Reporting Person Date
By: Chase Capital Partners, as Manager
By:
-------------------------------------------
Title: of Chase Capital Partners
-----------------------------
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, See Instruction 6 for procedure.
Page 2 of 7
<PAGE>
<TABLE>
<CAPTION>
- - ----------------------------------------------------------------------------------------------------------------
Title of
Derivative
Securities and
Title and Amount
of Securities
Date of Event Title and Underlying
Name and Address of Designated Requiring Issuer Name, Ticker Amount of Derivative
Reporting Person Reporter(1) Statement or Trading Symbol Security Securities
- - ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
John R. Baron Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ----------------------------------------------------------------------------------------------------------------
Mitchell J. Blutt Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ----------------------------------------------------------------------------------------------------------------
Chris C. Behrens Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ----------------------------------------------------------------------------------------------------------------
Arnold L. Chavkin Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ----------------------------------------------------------------------------------------------------------------
Eric Green Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 100
- - ----------------------------------------------------------------------------------------------------------------
Michael R. Hannon Chase Venture January 1, Diatide, Inc. Common Stock See Table II Above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ----------------------------------------------------------------------------------------------------------------
Donald J. Hofmann Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ----------------------------------------------------------------------------------------------------------------
<CAPTION>
- - ------------------------------------------------------------------------------------------------
Ownership Form: Disclaims
Name and Address of Designated Direct (D) or Nature of Indirect Pecuniary
Reporting Person Reporter(1) Indirect (I) Beneficial Ownership Interest
- - ------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
John R. Baron Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Mitchell J. Blutt Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Chris C. Behrens Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Arnold L. Chavkin Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Eric Green Chase Venture I See Explanatory Yes
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 100
- - ------------------------------------------------------------------------------------------------
Michael R. Hannon Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Donald J. Hofmann Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
</TABLE>
Page 3 of 7
<PAGE>
<TABLE>
<CAPTION>
- - ------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
Stephen P. Murray Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
John M.B. O'Connor Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
C/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
Susan L. Segal Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
Shahan D. Soghikian Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
50 California
Street, Suite 2940
San Francisco, CA
94111
- - ------------------------------------------------------------------------------------------------------------------
Jeffrey C. Walker Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
Timothy J. Walsh Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
Richard D. Waters Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
Damion E. Wicker Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
<CAPTION>
- - ------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Stephen P. Murray Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
John M.B. O'Connor Chase Venture I See Explanatory No
C/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Susan L. Segal Chase Venture I See Explanatory Yes
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Shahan D. Soghikian Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
50 California
Street, Suite 2940
San Francisco, CA
94111
- - ------------------------------------------------------------------------------------------------
Jeffrey C. Walker Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Timothy J. Walsh Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Richard D. Waters Chase Venture I See Explanatory Yes
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Damion E. Wicker Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
</TABLE>
Page 4 of 7
<PAGE>
<TABLE>
<CAPTION>
- - ------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
CCP European Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
Principals, LLC Capital 2000 ("DITI") 651,000
c/o Chase Capital Associates, LLC
Partners
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
CCP Principals, LLC Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
Chase Capital Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
Corporation Capital 2000 ("DITI") 651,000
(f/k/a Chemical Associates, LLC
Capital Corporation)
c/o Chase Capital
Partners
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
The Chase Manhattan Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
Corporation Capital 2000 ("DITI") 651,000
270 Park Avenue Associates, LLC
35th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
Chase Capital Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
Partners Capital 2000 ("DITI") 651,000
380 Madison Avenue Associates, LLC
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
CCP-SBIC Manager, LLC Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
CCP-CMC Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
Consolidating, LLC Capital 2000 ("DITI") 651,000
c/o Chase Capital Associates, LLC
Partners
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
David L. Ferguson Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------------------------
<CAPTION>
- - ------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
CCP European Chase Venture I See Explanatory No
Principals, LLC Capital Note 2 below
c/o Chase Capital Associates, LLC
Partners
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
CCP Principals, LLC Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 2 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Chase Capital Chase Venture I See Explanatory No
Corporation Capital Note 2 below
(f/k/a Chemical Associates, LLC
Capital Corporation)
c/o Chase Capital
Partners
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
The Chase Manhattan Chase Venture I See Explanatory No
Corporation Capital Note 3 below
270 Park Avenue Associates, LLC
35th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
Chase Capital Chase Venture I See Explanatory No
Partners Capital Note 4 below
380 Madison Avenue Associates, LLC
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
CCP-SBIC Manager, LLC Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 5 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
CCP-CMC Chase Venture I See Explanatory No
Consolidating, LLC Capital Note 6 below
c/o Chase Capital Associates, LLC
Partners
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
David L. Ferguson Chase Venture I See Explanatory No
c/o Chase Capital Capital Note 7 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - ------------------------------------------------------------------------------------------------
</TABLE>
Page 5 of 7
<PAGE>
<TABLE>
<CAPTION>
- - -------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
I. Robert Greene Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
c/o Flatiron Partners Capital 2000 ("DITI") 651,000
257 Park Avenue South Associates, LLC
12th Floor
New York, NY 10010
- - -------------------------------------------------------------------------------------------------------------------
Brian J. Richmand Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
C/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - -------------------------------------------------------------------------------------------------------------------
Jonas Steinmann Chase Venture January 1, Diatide, Inc. Common Stock See Table II above
C/o Chase Capital Capital 2000 ("DITI") 651,000
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - -------------------------------------------------------------------------------------------------------------------
<CAPTION>
- - -----------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
I. Robert Greene Chase Venture I See Explanatory No
c/o Flatiron Partners Capital Note 8 below
257 Park Avenue South Associates, LLC
12th Floor
New York, NY 10010
- - -----------------------------------------------------------------------------------------------
Brian J. Richmand Chase Venture I See Explanatory No
C/o Chase Capital Capital Note 9 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - -----------------------------------------------------------------------------------------------
Jonas Steinmann Chase Venture I See Explanatory No
C/o Chase Capital Capital Note 10 below
Partners Associates, LLC
380 Madison Avenue
12th Floor
New York, NY 10017
- - -----------------------------------------------------------------------------------------------
</TABLE>
Explanatory Note:
1) The Designated Reporter is executing this report on behalf of all reporting
persons, each of whom has authorized it to do so.
2) The amounts shown in Tables I and II represent the beneficial ownership of
the Issuer's equity securities by CVCA, LLC, a portion of which may be deemed
attributable to the reporting person because the reporting person is a partner
of Chase Capital Partners ("CCP"), which is the sole managing member of (a)
CCP--SBIC Manager, LLC ("CCP-SBIC"), the sole managing member of CVCA, LLC and
(b) CCP-CMC Consolidating, LLC, the non-managing member of CVCA, LLC. CCP is
also the manager, by delegation, of CVCA, LLC, pursuant to an advisory agreement
with CCP-SBIC and Consolidating. The actual pro rata portion of such beneficial
ownership that may be deemed to be attributable to the reporting person is not
readily determinable because it is subject to several variables, including the
internal rate of return and vesting of interests within CCP and CVCA, LLC.
3) The amounts shown in Tables I and II represent the beneficial ownership of
the Issuer's equity securities by CVCA, LLC, a portion of which may be deemed
attributable to the reporting person because it is the sole stockholder of Chase
Capital Corporation, a general partner of CCP, the sole managing member of the
two members of CVCA, LLC and the manager, by delegation, of CVCA, LLC. The
actual pro rata portion of such beneficial ownership that may be attributable to
the reporting person is not readily determinable because it is subject to
several variables, including the internal rate of return and vesting of
interests within CCP and CVCA, LLC.
4) The amounts shown in Tables I and II represent the beneficial ownership of
the Issuer's equity securities by CVCA, LLC, a portion of which may be deemed
attributable to the reporting person because it is the sole managing member of
(a) CCP-SBIC, the sole managing member of CVCA, LLC and (b) CCP-CMC
Consolidating, LLC, the non-managing member of CVCA, LLC. CCP is also the
manager, by delegation, of CVCA, LLC pursuant to an advisory agreement with
CCP-SBIC and Consolidating. The actual pro rata portion of such beneficial
ownership that may be deemed to be attributable to the reporting person is not
readily determinable because it is subject to several variables, including the
internal rate of return and vesting of interests within CCP and CVCA, LLC.
5) The amounts shown in Tables I and II represent the beneficial ownership of
the Issuer's equity securities by CVCA, LLC, a portion of which may be deemed
attributable to the reporting person because it is the sole managing member of
CVCA, LLC. The actual pro rata portion of such beneficial ownership that may be
deemed to be attributable to the reporting person is not readily determinable
because it is subject to several variables, including the internal rate of
return and vesting of interests within CVCA, LLC.
6) The amounts shown in Tables I and II represent the beneficial ownership of
the Issuer's equity securities by CVCA, LLC, a portion of which may be deemed
attributable to the reporting person because it is the sole non-managing member
of CVCA, LLC. The actual pro rata portion of such beneficial ownership that may
be deemed to be attributable to the reporting person is not readily determinable
because it is subject to several variables, including the internal rate of
return and vesting of interests within CCP and CVCA, LLC.
7) The amounts shown in Tables I and II represent the beneficial ownership of
the Issuer's equity securities by CVCA, LLC, a portion of which may be deemed
attributable to the reporting person because he was a general partner of CCP,
the sole managing member of the two members of CVCA, LLC and the manager, by
delegation, of CVCA, LLC, until June 1, 1999. The actual pro rata portion of
such beneficial ownership that may be deemed to be attributable to the reporting
person is not readily determinable because it is subject to several variables,
including the internal rate of return and vesting within CCP and CVCA, LLC.
Page 6 of 7
<PAGE>
8) The amounts shown in Tables I and II represent the beneficial ownership of
the Issuer's equity securities by CVCA, LLC, a portion of which may be deemed
attributable to the reporting person because he was a general partner of CCP,
the sole managing member of the two members of CVCA, LLC and the manager, by
delegation, of CVCA, LLC, until May 31, 1999. The actual pro rata portion of
such beneficial ownership that may be deemed to be attributable to the reporting
person is not readily determinable because it is subject to several variables,
including the internal rate of return and vesting within CCP and CVCA, LLC.
9) The amounts shown in Tables I and II represent the beneficial ownership of
the Issuer's equity securities by CVCA, LLC, a portion of which may be deemed
attributable to the reporting person because he was a general partner of CCP,
the sole managing member of the two members of CVCA, LLC and the manager, by
delegation, of CVCA, LLC, until December 31, 1999. The actual pro rata portion
of such beneficial ownership that may be deemed to be attributable to the
reporting person is not readily determinable because it is subject to several
variables, including the internal rate of return and vesting within CCP and
CVCA, LLC.
10) The amounts shown in Tables I and II represent the beneficial ownership of
the Issuer's equity securities by CVCA, LLC, a portion of which may be deemed
attributable to the reporting person because he was a general partner of CCP,
the sole managing member of the two members of CVCA, LLC, and the manager, by
delegation, of CVCA, LLC, until July 1, 1999. The actual pro rata portion of
such beneficial ownership that may be deemed to be attributable to the reporting
person is not readily determinable because it is subject to several variables,
including the internal rate of return and vesting within CCP and CVCA, LLC.
Page 7 of 7